Our Business

Phosphagenics Limited is a Melbourne-based biotechnology company which has developed a unique delivery technology based on tocopherol phosphate (Vitamin E phosphate). This platform technology, known as TPM® is able to deliver actives and drugs into or through the skin.

Phosphagenics shares are listed on the Australian Securities Exchange (ASX: POH), where it is quoted within the S&P/ASX300 Index.  Phosphagenics ADR’s are also traded on the OTCQX in the US.



 

Breaking News

14 May 2013

PHOSPHAGENICS SIGNS RESEARCH AGREEMENT WITH THE AGRICULTURAL RESEARCH SERVICE

  • Collaboration with the U.S. Department of Agriculture’s (USDA), Agricultural Research Service (ARS) in treatment of mastitis
  • Major global market opportunity
  • Trials to being in the second half 2013

Phosphagenics will collaborate with the U.S. Department of Agriculture’s (USDA), Agricultural Research Service (ARS) to develop and trial products targeting the serious bacterial infection mastitis in dairy cows.   ARS is the USDA’s chief intramural scientific research agency.

15 April 2013

PHOSPHAGENICS' PARTNER THEMIS COMPLETES SUPPLY AGREEMENT WITH NOVARTIS FOR TPM/DICLOFENAC GEL

  • Themis Medicare completes manufacturing and supply agreement with Novartis for TPM/diclofenac gel
  • This is in line with our strategy to expand the TPM® technology globally

Phosphagenics today announced that its commercial partner, Themis Medicare Limited, made the following release to the Bombay Stock Exchange (BSE) post market on Friday 12 April.  The release relates to the manufacture and supply of their specially formulated TPM/diclofenac gel to Novartis India Limited.



    ANNUAL GENERAL MEETING of shareholders was held on Friday, 17 May, at Minter Ellison, 525 Collins Street, Melbourne - Resolutions/CEO presentation:  http://www.phosphagenics.com/Investors/News_Releases_Presentations.aspx



    View our latest NEWSLETTER MAY 2013


    View reports on POH from:

    PhillipCapital Jan 2013
     
    Nomura Dec 2012

    Macquarie Dec 2012

    Which emerging technology companies will shape 2013 - from Lux Research Dec 2012

    Bell Potter Sept 2012


    For full releases refer to Investors/News Releases